ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00673556
Recruitment Status : Completed
First Posted : May 7, 2008
Last Update Posted : August 26, 2014
Sponsor:
Collaborator:
Biogen
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2005
  Actual Study Completion Date : May 2005